Amniox Medical, Inc. – Trademark Portfolio

Entity Type: 03

Amniox Medical, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NEOX. The owner is based in Atlanta, GA.

2849 Paces Ferry Road, Suite 750

Atlanta, GA 30339

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLARIX
CLARIX
Cancelled 2012
AM3
AM3
Cancelled 2012
CRYOTEK
CRYOTEK
Abandoned 2012
AMNIOX
AMNIOX
Cancelled 2012
AMNIOX
AMNIOX
Cancelled 2012
NEOX
NEOX
Registered 2012
NEOX
NEOX
Registered 2012

Trademark Classifications

Amniox Medical, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does Amniox Medical, Inc. have?

Amniox Medical, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 4 cancelled.

What trademark classes does Amniox Medical, Inc. file in?

Amniox Medical, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Amniox Medical, Inc.'s most well-known trademarks?

Amniox Medical, Inc.'s registered trademark portfolio includes well-known marks such as NEOX. These are among 2 currently registered trademarks in the portfolio.

What is Amniox Medical, Inc.'s trademark registration success rate?

Amniox Medical, Inc. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.